Opportunity in Tuberculosis

Mitelos is looking for distributors for a product able to induce the balanced immune response that diminish the risk of acquiring TB. Its production is based in the elaboration of a heat-killed culture of an environmental micobacteria belonging to the family of Mycobacterium fortuitum complex (new species: Mycobacterium manresensis). The final active ingredient is a powder with a known concentration of a low dose heat-killed bacteria plus an excipient. After giving it daily for 14 days, it has been demonstrated that is able to stop the progression towards active Tuberculosis in preclinical assays.